These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 15304626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postmarketing hepatic adverse event experience with PEGylated/non-PEGylated drugs: a disproportionality analysis.
    Hauben M, Vegni F, Reich L, Younus M.
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):934-41. PubMed ID: 18049161
    [Abstract] [Full Text] [Related]

  • 3. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
    Hauben M, Reich L, Gerrits CM.
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety related drug-labelling changes: findings from two data mining algorithms.
    Hauben M, Reich L.
    Drug Saf; 2004 Nov; 27(10):735-44. PubMed ID: 15350157
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.
    Lehman HP, Chen J, Gould AL, Kassekert R, Beninger PR, Carney R, Goldberg M, Goss MA, Kidos K, Sharrar RG, Shields K, Sweet A, Wiholm BE, Honig PK.
    Clin Pharmacol Ther; 2007 Aug; 82(2):173-80. PubMed ID: 17507922
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions.
    Fraunfelder FW, Fraunfelder FT.
    Am J Ophthalmol; 2007 Jan; 143(1):145-149. PubMed ID: 17188050
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms.
    Hauben M, Reich L, Chung S.
    Eur J Clin Pharmacol; 2004 Dec; 60(10):747-50. PubMed ID: 15619136
    [Abstract] [Full Text] [Related]

  • 14. Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation.
    Hauben M, Reich L.
    J Clin Pharmacol; 2005 Apr; 45(4):378-84. PubMed ID: 15778418
    [Abstract] [Full Text] [Related]

  • 15. Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
    Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The state of adverse event reporting and signal generation of dietary supplements in Korea.
    Park KS, Kwon O.
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):74-7. PubMed ID: 20074608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.